Source: Annual Congress 2010 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Pittrow, D. Vizza, A. Vonk-Noordegraaf, C. Opitz, D. Huscher, H. A. Ghofrani, J. L. Vachiery, S. Gaine, O. Distler, S. Gibbs, M. Hoeper (Dresden, Berlin, Hannover, Giessen, Germany; Amsterdam, Netherlands; Brussels, Belgium; Dublin, Ireland; , Switzerland; London, United Kingdom; Rome, Italy). CompERA-XL: International, prospective registry for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension. Eur Respir J 2010; 36: Suppl. 54, 3520

Member's Comments

No comment yet.

Related content which might interest you: Issues related to the management and therapy of paediatric pulmonary hypertension Source: Eur Respir Rev 2010 19: 331-339 Year: 2010 Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs Source: Eur Respir Rev 2009; 18: 18-23 Year: 2009 Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: Randomised controlled trial Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Safety and efficacy of home-based pulmonary rehabilitation in patients with pulmonary hypertension: Feasibility study of 12 cases Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 Safety and benefit of adjunctive systemic corticosteroid therapy in the management of severe, smear positive pulmonary tuberculosis (SSP-PTB); an interim analysis of a randomized controlled trial Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Oral anticoagulation therapy in pediatric pulmonary hypertension: A 10-year registry survival analysis Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 Registries for paediatric pulmonary hypertension Source: Eur Respir J 2013; 42: 580-583 Year: 2013 Patients’ adherence to chronic treatment in lung diseases: Preliminary data from a randomized controlled trial Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Long–term follow-up of patients on sildenafil from Croatian pulmonary hypertension registry Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial Source: ERJ Open Res, 5 (3) 00110-2019; 10.1183/23120541.00110-2019 Year: 2019 Multi-institutional prospective cohort study of prognostic factors in patients with idiopathic pulmonary fibrosis receiving long-term oxygen therapy. Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006 Economic evaluation of the impact of exacerbation frequency in COPD patients treated with single-inhaler triple therapy in Spain: The IMPACT trial Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Pulmonary rehabilitation in patients with group 3 pulmonary hypertension: evaluation of clinical outcomes, adherence and safety. Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019 Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019 Year: 2020 Clinical effect of combined chemotherapy according to guidelines fro the treatment of pulmonary Mtcobacterium complex disease, including a follow-up study. Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Current epoprostenol use in patients with severe pulmonary hypertension (PH): Data from the French PH registry Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study Source: Eur Respir J 2014; 43: 1691-1697 Year: 2014